share_log

格隆汇公告精选(港股)︱福耀玻璃(03606.HK)公布年度业绩:净利润增18.37%至56.29亿元,预计2024年全年资金需求410.16亿元

Gelonghui Announcements Selected (Hong Kong Stocks) | Fuyao Glass (03606.HK) Announces Annual Results: Net Profit Increased by 18.37% to RMB 5.629 billion, with an estimated capital requirement of RMB 41,016 billion for the full year of 2024

Gelonghui Finance ·  Mar 15 11:20

[Today's focus]

Fuyao Glass (03606.HK) announced its annual results: net profit increased 18.37% to 5.629 billion yuan, and the estimated capital requirement for 2024 is 41,016 billion yuan

Fuyao Glass (03606.HK) announced annual results. For the year ended December 31, 2023, the company achieved consolidated revenue of RMB 33.161 billion, an increase of 18.02% over the same period of the previous year; realized profit before tax of RMB 6.715 billion, an increase of 20.38% over the same period of the previous year; achieved annual profit attributable to the company's owners of RMB 5.629 billion, an increase of 18.37% over the same period of the previous year; and achieved earnings per share of RMB 2.16, an increase of 18.68% over the same period last year. It is proposed to distribute a cash dividend of RMB 1.30 (tax included) per share.

The company selects representative financial indicators from profitability, operating ability, and solvency to analyze the company's ability to grow. The company's revenue in 2023 increased 18.02% year on year, annual profit increased 18.44% year on year, and profitability continued to strengthen; the company's 2023 trade receivables turnover days and inventory turnover days were 85 days and 90 days respectively to maintain the company's normal turnover efficiency level; the company's balance ratio on December 31, 2023 was 44.52%, maintaining strong solvency. The company continuously strengthens the operation and management of the enterprise, enhances the overall competitiveness of the enterprise, and continuously creates value for shareholders.

Furthermore, in order to complete the 2024 business plan and work goals, the company expects capital requirements for the full year of 2024 to be RMB 41,016 billion, including operating expenses of RMB 29.5 billion, capital expenditure of RMB 8.123 billion, and payment of cash dividends of RMB 3.393 billion. The plan is to resolve this by speeding up sales payment returns and inventory turnover, optimizing the use of saved funds, and borrowing or issuing bonds from financial institutions. In 2024, the company will continue to strengthen comprehensive budget management, strengthen payment returns, strictly control exchange rate risks, optimize capital structure, and make fund management safe and effective.

[Important matters]

Dalip Holdings (01921.HK) plans to establish a regional headquarters, R&D center, smart factory and data control center in the Middle East

[Financial results]

GCL Technology (03800.HK) will continue operating business revenue of about 33.7 billion yuan in 2023

Dongyao Pharmaceutical-B (01875.HK) announced annual results, a sharp increase in revenue of 77%, and the group's hematopoietic capacity continued to increase

Profit attributable to owners of Huajian Healthcare (01931.HK)'s 2023 parent company increased 13.4% year-on-year

Zhongguancun Technology Leasing (01601.HK)'s annual profit of about 260 million yuan increased by about 14.9% year-on-year

Xincheng Development (01030.HK) Yingxi: Expected net profit of 800 million yuan to 1 billion yuan in 2023

Huiliang Technology (01860.HK)'s annual revenue of US$1,054 million increased 17.9% year-on-year

Phoenix TV (02008.HK)'s annual revenue of approximately HK$2,468 billion decreased by 17.8% year-on-year

Guangdong Transportation (03399.HK) turned a loss into a profit of 202 million yuan in 2023

Kang Qiaoyue Life's 2023 results released: revenue of about 934 million yuan, up 17.8% year-on-year

Qinqin Foods (01583.HK)'s cumulative sales revenue in 2023 was about 980 million yuan, up 2.5% year-on-year

Shanshui Cement (00691.HK)'s revenue in 2023 was about 18.116 billion yuan, a year-on-year decrease of 15.7%

Luzhu Bio-B (02480.HK)'s annual adjusted loss increased by about 46.6% to about 223 million yuan

Xingfa Aluminum (00098.HK) Yingxi: Expected annual net profit of not less than 780 million yuan

China Glass (03300.HK) Profit Alert: Expected loss of no more than 500 million yuan in 2023

Jiutai Bangda Energy (02798.HK) expects net profit of about 470 million yuan to 520 million yuan after tax in 2023

Jiutai Agricultural Commercial Bank (06122.HK) expects annual net profit to drop by about 85%

Yunfeng Financial (00376.HK) expects annual profit of approximately HK$390 million to turn a loss into a profit year over year

Java Holdings (00251.HK) Profit Alert: Expected to lose approximately HK$850 million in 2023

[Operational data]

Longhu Group (00960.HK)'s total contract sales amount in February was 5.75 billion yuan

Air China (00753.HK) passenger turnover in February increased 70.0% year on year and 8.2% month on month

China Southern Airlines Co., Ltd. (01055.HK) passenger turnover increased 55.49% year-on-year in February

China Eastern Airlines Co., Ltd. (00670.HK): Passenger capacity investment increased 57.81% year-on-year in February, passenger turnover increased 80.3%

Xinhua Insurance (01336.HK) accumulated original premium income of 39.6 billion yuan from January to February

China Coal Energy (01898.HK): Commercial coal sales in February fell 16.2% year-on-year to 18.28 million tons

[Pharmaceutical Innovation]

Xiansheng Pharmaceutical (02096.HK): Application for marketing of a new injectable sulvicitamab drug was accepted by the State Drug Administration

China Biopharmaceutical (01177.HK): “ranilano” (pan-PPAR agonist) and “TQA2225" (recombinant human FGF21-FC fusion protein) are currently undergoing phase III and phase II clinical trials in China, respectively

[Acquisition and sale]

Intercontinental Shipping (02409.HK) plans to buy an oil tanker for US$30.1 million

Lai Sun Development (00488.HK) plans to sell Hong Kong properties for HK$80 million

Qiangtai Environmental Protection (01395.HK) plans to sell wood pellet production business

[Equity Incentives]

Ali Health (00241.HK) grants a total of 1.93 million restricted share units

[Repurchase Cancellation]

AIA (01299.HK) spent HK$280 million to repurchase 4.6 million shares on March 15

Standard Chartered Group (02888.HK) spent £2.59 million to buy back 3.85 million shares on March 14

HSBC Holdings (00005.HK) spent HK$904.21 million to repurchase 1,528,400 shares on March 14

The Board of Directors of Huiliang Technology (01860.HK) approved a capital increase of HK$80 million to the current share repurchase plan

Yum China (09987.HK) spent HK$38.272,800 to buy back 114,400 shares on March 14

Haier Smart Home (06690.HK) spent 28.47 million yuan to buy back 1.193 million A shares on March 15

Kuaishou-W (01024.HK) spent HK$24.78 million to buy back 503,000 shares on March 15

Gloria Ying (06821.HK) spent 1999 million yuan to buy back 201,000 A shares on March 15

Swire Group A (00019.HK) spent HK$16.66,800 to repurchase 252,000 shares on March 15

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment